RHHVF
Price
$331.83
Change
+$2.60 (+0.79%)
Updated
Sep 17 closing price
Capitalization
266.6B
34 days until earnings call
SNPHY
Price
$10.95
Change
-$0.32 (-2.84%)
Updated
Sep 17 closing price
Capitalization
3.69B
Interact to see
Advertisement

RHHVF vs SNPHY

Header iconRHHVF vs SNPHY Comparison
Open Charts RHHVF vs SNPHYBanner chart's image
Roche Holding
Price$331.83
Change+$2.60 (+0.79%)
Volume$963
Capitalization266.6B
Santen Pharmaceutical
Price$10.95
Change-$0.32 (-2.84%)
Volume$13.52K
Capitalization3.69B
RHHVF vs SNPHY Comparison Chart in %
Loading...
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RHHVF vs. SNPHY commentary
Sep 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RHHVF is a Hold and SNPHY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 19, 2025
Stock price -- (RHHVF: $326.23 vs. SNPHY: $10.90)
Brand notoriety: RHHVF and SNPHY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHVF: 4% vs. SNPHY: 14%
Market capitalization -- RHHVF: $266.6B vs. SNPHY: $3.69B
RHHVF [@Pharmaceuticals: Major] is valued at $266.6B. SNPHY’s [@Pharmaceuticals: Major] market capitalization is $3.69B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $683.93B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHVF’s FA Score shows that 1 FA rating(s) are green whileSNPHY’s FA Score has 1 green FA rating(s).

  • RHHVF’s FA Score: 1 green, 4 red.
  • SNPHY’s FA Score: 1 green, 4 red.
According to our system of comparison, RHHVF is a better buy in the long-term than SNPHY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHVF’s TA Score shows that 5 TA indicator(s) are bullish while SNPHY’s TA Score has 5 bullish TA indicator(s).

  • RHHVF’s TA Score: 5 bullish, 5 bearish.
  • SNPHY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SNPHY is a better buy in the short-term than RHHVF.

Price Growth

RHHVF (@Pharmaceuticals: Major) experienced а -3.65% price change this week, while SNPHY (@Pharmaceuticals: Major) price change was -3.96% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.23%. For the same industry, the average monthly price growth was -0.39%, and the average quarterly price growth was +11.28%.

Reported Earning Dates

RHHVF is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.23% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHVF($267B) has a higher market cap than SNPHY($3.69B). RHHVF has higher P/E ratio than SNPHY: RHHVF (21.84) vs SNPHY (15.39). RHHVF YTD gains are higher at: 16.511 vs. SNPHY (7.708). SNPHY has higher annual earnings (EBITDA): 51.1B vs. RHHVF (18B). SNPHY has more cash in the bank: 85.9B vs. RHHVF (12B). SNPHY has higher revenues than RHHVF: SNPHY (303B) vs RHHVF (63.5B).
RHHVFSNPHYRHHVF / SNPHY
Capitalization267B3.69B7,232%
EBITDA18B51.1B35%
Gain YTD16.5117.708214%
P/E Ratio21.8415.39142%
Revenue63.5B303B21%
Total Cash12B85.9B14%
Total Debt33BN/A-
FUNDAMENTALS RATINGS
RHHVF vs SNPHY: Fundamental Ratings
RHHVF
SNPHY
OUTLOOK RATING
1..100
6187
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5654
P/E GROWTH RATING
1..100
3586
SEASONALITY SCORE
1..100
n/a24

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHVF's Valuation (13) in the null industry is in the same range as SNPHY (33). This means that RHHVF’s stock grew similarly to SNPHY’s over the last 12 months.

RHHVF's Profit vs Risk Rating (100) in the null industry is in the same range as SNPHY (100). This means that RHHVF’s stock grew similarly to SNPHY’s over the last 12 months.

RHHVF's SMR Rating (99) in the null industry is in the same range as SNPHY (100). This means that RHHVF’s stock grew similarly to SNPHY’s over the last 12 months.

SNPHY's Price Growth Rating (54) in the null industry is in the same range as RHHVF (56). This means that SNPHY’s stock grew similarly to RHHVF’s over the last 12 months.

RHHVF's P/E Growth Rating (35) in the null industry is somewhat better than the same rating for SNPHY (86). This means that RHHVF’s stock grew somewhat faster than SNPHY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RHHVFSNPHY
RSI
ODDS (%)
Bearish Trend 2 days ago
46%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
53%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 14 days ago
52%
Bullish Trend 3 days ago
53%
Declines
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 7 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OYRDX29.34N/A
N/A
Invesco Rising Dividends Y
AGIFX21.05N/A
N/A
Alger Responsible Investing I
BCBDX13.18N/A
N/A
BlackRock Global Dividend Inv C
CDDYX37.34N/A
N/A
Columbia Dividend Income Inst3
MNOZX37.06N/A
N/A
Manning & Napier Overseas Series Z

RHHVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHVF has been loosely correlated with RHHBY. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHVF jumps, then RHHBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHVF
1D Price
Change %
RHHVF100%
-1.69%
RHHBY - RHHVF
65%
Loosely correlated
+0.05%
JNJ - RHHVF
31%
Poorly correlated
-1.72%
NVS - RHHVF
27%
Poorly correlated
-0.15%
AZN - RHHVF
26%
Poorly correlated
-0.80%
RHHBF - RHHVF
25%
Poorly correlated
-0.47%
More

SNPHY and

Correlation & Price change

A.I.dvisor tells us that SNPHY and RHHBF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHY and RHHBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHY
1D Price
Change %
SNPHY100%
-0.47%
RHHBF - SNPHY
9%
Poorly correlated
-0.47%
RHHVF - SNPHY
9%
Poorly correlated
-1.69%
RHHBY - SNPHY
6%
Poorly correlated
+0.05%
OTSKY - SNPHY
3%
Poorly correlated
+0.09%
SNPHF - SNPHY
1%
Poorly correlated
N/A
More